Sofosbuvir impurity I Catalog No.:M14935-2 is an inhibitor of non-mammalian

is an inhibitor of non-mammalian and mammalian β-glucosidase

revealing a unique role for lipid metabolism in hPSCs

KDM4B-IN-B3 displays high selectivity for the fast-growing AR-negative PC3 cells (IC50=40 nM) and over 100-fold selectivity against the immortalized prostate epithelial cell lines PrEC1 and PrEC4

Smiles: COC1C=CC(CN2C=C(C(O)=O)C(=O)C3C=CC=CC2=3)=CC=1

Molecularly targeted therapies in non-small cell lung cancer: The evolving role of tyrosine kinase inhibitors

Sofosbuvir impurity I Catalog No.:M14935-2 is an inhibitor of non-mammalianSofosbuvir impurity I, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI 7977) is an inhibitor of HCV RNA replication, demonstrates potent anti hepatitis C virus activity. Product information CAS Number: 2164516 85 0 Molecular Weight: 515. 43 Formula: C21H27FN3O9P Chemical Name: ethyl (2S) 2 {[(S) {[(2R,3R,4R,5R) 5 (2,4 dioxo 1,2,3,4 tetrahydropyrimidin 1 yl) 4 fluoro 3 hydroxy 4 methyloxolan 2